This is a StreetInsider.com Premium Only Page

iShares 20+ Year Treasury Bond ETF (TLT) – Press Releases

Apr 26, 2023 06:01 PM Theralase® Releases FY2022 Audited Financial Statements

Feb 23, 2023 07:00 AM Theralase® Phase II NMIBC Clinical Study (Interim) Data Presented at the ASCO GU Cancer Symposium

Feb 21, 2023 07:35 AM Theralase® Awarded TSX Venture 50™ Recognition as a Top Performing Company

Feb 2, 2023 07:00 AM Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the AUA Annual Meeting

Jan 25, 2023 07:00 AM Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the ASCO GU Cancer Symposium

Jan 5, 2023 06:17 PM Theralase ® Announces Warrant Extension

Nov 29, 2022 06:43 PM Theralase Releases Q322 Interim Financial Statements

Nov 21, 2022 07:00 AM Theralase® Grants Stock Options

Nov 17, 2022 05:24 PM Theralase ® Closes Private Placement Equity Financing

Sep 29, 2022 05:00 PM Theralase® Announces Warrant Extension

Sep 22, 2022 05:55 PM Theralase® Closes $2.5M Private Placement Equity Financing

Aug 29, 2022 07:45 PM Theralase Releases Q222 Interim Financial Statements

Aug 22, 2022 09:30 AM BlackRock Launches Industry’s First BuyWrite Fixed Income ETFs

Jun 28, 2022 07:00 AM Theralase Expands Intellectual Property Portfolio

Jun 24, 2022 07:00 AM Theralase® Research - One of the Top 10 Most Downloaded Papers

Jun 21, 2022 07:00 AM Theralase® Phase Ib NMIBC Clinical Study Published

May 30, 2022 05:53 PM Theralase Releases Q122 Interim Financial Statements

Apr 29, 2022 09:11 PM Theralase Release FY2021 Audited Financial Statements

Apr 5, 2022 07:00 AM Theralase® Provides Update on Phase II Bladder Cancer Clinical Study

Feb 7, 2022 07:00 AM Theralase® Demonstrates Proof-of-Concept for Canadian-Made COVID-19 Vaccine

Dec 9, 2021 07:00 AM Theralase Expands Intellectual Property Portfolio

Nov 29, 2021 06:00 PM Theralase Releases 3Q21 Financial Statements and Newsletter

Nov 15, 2021 04:25 PM Theralase Announces Leadership Reorganization

Aug 30, 2021 06:15 PM Theralase Releases Q221 Unaudited Financial Statements and Quarterly Newsletter

Aug 19, 2021 04:49 PM Theralase Announces Leadership Transition

Jun 11, 2021 07:00 AM Theralase® Launches Seventh US-Based Clinical Study Site and Treats First Patient in the US

May 28, 2021 06:58 PM Theralase Releases Q12021 Interim Financial Statements

Dec 21, 2020 08:35 AM Life Sciences Company Investor Presentations Now Available for On-Demand Viewing

Dec 14, 2020 08:28 AM Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020

Jun 2, 2017 07:00 AM OTC Markets Group Welcomes Theralase Technologies Inc. to OTCQX

Sep 6, 2016 09:00 AM MicroCap Review Magazine Fall 2016 Issue Now Available

Sep 6, 2016 09:00 AM MicroCap Review Magazine Fall 2016 Issue Now Available

Feb 26, 2016 10:00 AM BlackRock’s iShares to Ring The Nasdaq Stock Market Closing Bell

Jan 29, 2016 07:30 AM BlackRock Announces Changes to Four iShares Treasury ETFs

Jan 5, 2016 08:30 AM BlackRock Announces Primary Listing Venue Changes for 11 iShares ETFs

Jun 4, 2015 08:00 AM Theralase Technologies Inc. (TLT) to Present at the Small-Cap Stars Spring Conference 2015 at Convene in Times Square New York on June 10